CEO Michael Kauffman sold $294K of Karyopharm Therapeutics Inc.

Sold$294,414

$19.63Price

15,000Shares

−1%Stake

What KPTI did after the filing

Prices for KPTI after this filing aren't in yet.

Traded Thu, May 7. Filed Mon, May 11, 12:19 PM ET, during the session. Not investment advice.